Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity

The effect of prolonged systemic doxycycline therapy on serum tissue degrading proteinases in coronary bypass patients: a randomized, double-masked, placebo-controlled clinical trial

(2013) Immi Kormi et al.   INFLAMMATION RESEARCH

Subantimicrobial-dose doxycycline treatment increases serum cholesterol efflux capacity from macrophages

(2013) Aino Salminen et al.   INFLAMMATION RESEARCH

Matrix metalloproteinase (MMP)-9: A proximal biomarker for cardiac remodeling and a distal biomarker for inflammation

(2013) Ganesh V. Halade et al.   PHARMACOLOGY & THERAPEUTICS

Recognition of Porphyromonas gingivalis Gingipain Epitopes by Natural IgM Binding to Malondialdehyde Modified Low-Density Lipoprotein

(2012) S. Pauliina Turunen et al.   PLoS One

Serum tissue-degrading proteinases and incident cardiovascular disease events

(2012) Anita M Tuomainen et al.   European Journal of Preventive Cardiology

Analysis of apolipoprotein A-I as a substrate for matrix metalloproteinase-14

(2011) Jun Hyoung Park et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Matrix metalloproteinase inhibition with tetracyclines for the treatment of coronary artery disease

(2011) Travis J. Bench et al.   PHARMACOLOGICAL RESEARCH

A Role of Matrix Metalloproteinase-8 in Atherosclerosis

(2009) Ross C. Laxton et al.   CIRCULATION RESEARCH

Subantimicrobial-Dose Doxycycline Modulates Gingival Crevicular Fluid Biomarkers of Periodontitis in Postmenopausal Osteopenic Women

(2008) Lorne M. Golub et al.   JOURNAL OF PERIODONTOLOGY